About Us

Health Care Committee

Chair: Mr. Damir Detić
Johnson&Johnson
Oreškovićeva 6H
10000 Zagreb
phone: +385.1.6610.708
e-mail: ddetic@its.jnj.com

Vice Chairs: Mr. Danko Schönwald
Novartis Hrvatska d.o.o.
Radnička cesta 37b
10000 Zagreb
phone: +385.1.6274.231
e-mail: danko.schonwald@novartis.com

Ms. Irena Stastny
Abbvie d.o.o.
Strojarska 20/11
10000 Zagreb
phone: +385.1.5625.502
e-mail: irena.stastny@abbvie.com


Mission statement:
The AmCham Health Care Committee represents the leading research-based pharmaceutical and biotechnology companies in the United States and Croatia. Member companies of the Committee are devoted to discovering and developing new medicines that will enable patients to live longer, healthier and more productive lives. In 2002 the companies invested more that $32 billion in discovering and developing new medicines, marking the 32nd straight year the industry has increased its investment in R&D.
The Committee’s mission is to conduct effective advocacy for public policies that encourage discovery of important innovative medicines for patients by pharmaceutical / biotechnology research companies.

2017 POLICY ISSUES

1. Patient access to innovative medicines and technologies:
• Therapeutic Price Referencing at the ATC-level 3 and 4
• Determination of listed price for medicines that are dispensed in hospitals at the level of the cheapest comparable medicine
• Limited options for innovative contracting
• Lack of objective criteria in reimbursement decision making

2. Consideration of alternative sources of financing
• Liberalization of the health insurance market (both compulsory and supplemental), (charity, foundation, grants)
• Better utilization of EU funds

3. Research and Development
• Removal of legal barriers for conducting clinical trials
• No legal framework for provision of compassionate use programs

4. Public Procurement in Healthcare
• Wider use of MEAT criterion in centralized public procurement bid selection
• Promotion of “free to choose” principle for public procurement of biosimilar drugs


5. Improving Fiscal Environment
• VAT rates on drugs/medical devices should be comparable to those in other EU countries
• Monitoring the application of the proclaimed 60 days payment rule

Committee Members:
3M (East) AG Podružnica RH - Maja Jukić Franušić, Nikolina Gregorić
Abbott Laboratories d.o.o. - Sanja Matić, Stanko Klipa
AbbVie d.o.o. - Ljubiša Mitof-Višurski, Irena Stastny
Amgen d.o.o. - Irena Hampel Hršak, Paulina Šafar
AstraZeneca d.o.o. - Damir Nevjestić
Bayer d.o.o. - Maja Drašković
Becton Dickinson Croatia d.o.o. - Robert Peričić, Ines Prološčić
Biomedica dijagnostika d.o.o. - Maja Kovač
Business Media Croatia d.o.o., Nenad Žunec
Eli Lilly (Suisse) S.A. - Predstavništvo u Hrvatskoj - Željko Miličević
Fresenius Medical Care Hrvatska d.o.o. - Nada Radin
General Electric International Inc. Glavna podružnica Zagreb - Sandra Senečić, Gabor Szell
GlaxoSmithKline d.o.o. - Marin Dumičić
Johnson & Johnson S.E. d.o.o. - Damir Detić, Tatjana Tomljanović
Medical Intertrade d.o.o. - Kristina Šoljak
Medtronic Adriatic d.o.o. - Hrvoje Badovinac, Branimir Gonan, Jurica Toth
Merck Sharp & Dohme d.o.o. - Jelka Drašković
Novartis Hrvatska d.o.o. - Danko Schönwald
Odvjetničko društvo Župić i partneri d.o.o. - Mirna Pavletić Župić
Olympus d.o.o. - Dražen Arbanas, Ivana Madunić
Pfizer Croatia d.o.o. - Mirijam Lucić
PHILIPS d.o.o. - Miroslav Šaban
Roche d.o.o. - Boris Lukovnjak, Csaba Dohoczky
SANDOZ d.o.o. - Igor Haralović, Karmen Klemente Maletić
U.S. Embassy - U.S. Commercial Service - Damjan Benčić
Udruga za istraživanja i razvoj ODAS - Ivana Božičević